About Tenaya Therapeutics, Inc. 
Tenaya Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 31 Schemes (9.57%)
Foreign Institutions
Held by 44 Foreign Institutions (3.76%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2026)
Net Profit:
-19 Million
Pharmaceuticals & Biotechnology
USD 186 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.64
-113.74%
2.24






